Prospects of cell replacement therapy for the treatment of degenerative cervical myelopathy
- 18 December 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Progress in Neurobiology
- Vol. 32 (3), 275-287
- https://doi.org/10.1515/revneuro-2020-0075
Abstract
Degenerative cervical myelopathy (DCM) presents insidiously during middle-age with deterioration in neurological function. It accounts for the most common cause of non-traumatic spinal cord injury in developed countries and disease prevalence is expected to rise with the aging population. Whilst surgery can prevent further deterioration, biological therapies may be required to restore neurological function in advanced disease. Cell replacement therapy has been inordinately focused on treatment of traumatic spinal cord injury yet holds immense promise in DCM. We build upon this thesis by reviewing the pathophysiology of DCM as revealed by cadaveric and molecular studies. Loss of oligodendrocytes and neurons occurs via apoptosis. The tissue microenvironment in DCM prior to end-stage disease is distinct from that following acute trauma, and in many ways more favourable to receiving exogenous cells. We highlight clinical considerations for cell replacement in DCM such as selection of cell type, timing and method of delivery, as well as biological treatment adjuncts. Critically, disease models often fail to mimic features of human pathology. We discuss directions for translational research towards clinical application.Funding Information
- Health and Medical Research Fund (06172326)
This publication has 88 references indexed in Scilit:
- The Prevalence and Phenotype of Activated Microglia/Macrophages within the Spinal Cord of the Hyperostotic Mouse (twy/twy) Changes in Response to Chronic Progressive Spinal Cord Compression: Implications for Human Cervical Compressive MyelopathyPLOS ONE, 2013
- Development and Characterization of a Novel Rat Model of Cervical Spondylotic Myelopathy: The Impact of Chronic Cord Compression on Clinical, Neuroanatomical, and Neurophysiological OutcomesJournal of Neurotrauma, 2012
- Evidence of an Inherited Predisposition for Cervical Spondylotic MyelopathySpine, 2012
- Postmortem findings in a woman with history of laminoplasty for severe cervical spondylotic myelopathyThe Journal of Spinal Cord Medicine, 2011
- Tight squeeze, slow burn: inflammation and the aetiology of cervical myelopathyBrain, 2011
- Oligodendrocyte Fate after Spinal Cord InjuryNeurotherapeutics, 2011
- Grafting of Human Bone Marrow Stromal Cells Into Spinal Cord InjurySpine, 2009
- Neurological recovery after surgical decompression in patients with cervical spondylotic myelopathy - a prospective studyInternational Orthopaedics, 2007
- The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injuryExperimental Neurology, 1995
- The Pathophysiology of Cervical Spondylosis and MyelopathySpine, 1988